A detailed history of Db Fitzpatrick & Co, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Db Fitzpatrick & Co, Inc holds 21,006 shares of EW stock, worth $1.4 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
21,006
Previous 20,940 0.32%
Holding current value
$1.4 Million
Previous $1.93 Million 28.34%
% of portfolio
1.23%
Previous 1.8%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$59.7 - $93.78 $3,940 - $6,189
66 Added 0.32%
21,006 $1.39 Million
Q2 2024

Jul 17, 2024

SELL
$84.3 - $94.31 $12,982 - $14,523
-154 Reduced 0.73%
20,940 $1.93 Million
Q1 2024

Apr 19, 2024

BUY
$72.54 - $95.56 $4,134 - $5,446
57 Added 0.27%
21,094 $2.02 Million
Q4 2023

Jan 23, 2024

BUY
$61.71 - $77.76 $198,274 - $249,842
3,213 Added 18.03%
21,037 $1.6 Million
Q3 2023

Nov 01, 2023

BUY
$69.28 - $93.38 $4,641 - $6,256
67 Added 0.38%
17,824 $1.23 Million
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $74,164 - $85,934
-911 Reduced 4.88%
17,757 $1.68 Million
Q1 2023

Apr 24, 2023

BUY
$74.26 - $84.51 $78,864 - $89,749
1,062 Added 6.03%
18,668 $1.54 Million
Q4 2022

Jan 24, 2023

BUY
$68.3 - $87.44 $1.2 Million - $1.54 Million
17,606 New
17,606 $0
Q3 2022

Oct 20, 2022

SELL
$82.37 - $107.29 $115,894 - $150,957
-1,407 Reduced 10.18%
12,410 $1.03 Million
Q2 2022

Jul 28, 2022

BUY
$86.5 - $128.27 $45,585 - $67,598
527 Added 3.97%
13,817 $1.31 Million
Q1 2022

Apr 22, 2022

BUY
$101.96 - $128.34 $30,587 - $38,502
300 Added 2.31%
13,290 $1.56 Million
Q4 2021

Feb 03, 2022

BUY
$106.37 - $130.68 $1.38 Million - $1.7 Million
12,990 New
12,990 $1.68 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.2B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Db Fitzpatrick & Co, Inc Portfolio

Follow Db Fitzpatrick & Co, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Db Fitzpatrick & Co, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Db Fitzpatrick & Co, Inc with notifications on news.